Harvard Bioscience (STU:HBI) 3-Year EBITDA Growth Rate : 12.10% (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Harvard Bioscience 3-Year EBITDA Growth Rate?

Harvard Bioscience's EBITDA per Share for the three months ended in Mar. 2024 was €-0.04.

During the past 12 months, Harvard Bioscience's average EBITDA Per Share Growth Rate was -77.30% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 12.10% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -12.40% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -1.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Harvard Bioscience was 55.20% per year. The lowest was -51.50% per year. And the median was -3.30% per year.

Competitive Comparison of Harvard Bioscience's 3-Year EBITDA Growth Rate

For the Medical Instruments & Supplies subindustry, Harvard Bioscience's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Harvard Bioscience's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Harvard Bioscience's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Harvard Bioscience's 3-Year EBITDA Growth Rate falls into.

Harvard Bioscience 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Harvard Bioscience (STU:HBI) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Harvard Bioscience 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Harvard Bioscience's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Harvard Bioscience (STU:HBI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Harvard Bioscience Inc (STU:HBI) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

HBIO:USA

Address

84 October Hill Road, Holliston, MA, USA, 01746

Website

https://www.harvardbioscience.com

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life science and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.